Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death in the real world: Main findings from the French multicentre DAI-PP programme (pilot phase).
Boveda S, Garcia R, Defaye P, Piot O, Narayanan K, Barra S, Gras D, Providencia R, Algalarrondo V, Beganton F, Perier MC, Jacob S, Bordachar P, Babuty D, Klug D, Leclercq C, Fauchier L, Sadoul N, Deharo JC, Marijon E; DAI-PP investigators. Boveda S, et al. Among authors: algalarrondo v. Arch Cardiovasc Dis. 2019 Aug-Sep;112(8-9):523-531. doi: 10.1016/j.acvd.2019.05.005. Epub 2019 Aug 27. Arch Cardiovasc Dis. 2019. PMID: 31471226 Free article. Review.
Detailed clinical, physiological and pathological phenotyping can impact access to disease-modifying treatments in ATTR carriers.
Beauvais D, Labeyrie C, Cauquil C, Francou B, Eliahou L, Not A, Echaniz-Laguna A, Adam C, Slama MS, Benmalek A, Leonardi L, Rouzet F, Adams D, Algalarrondo V, Beaudonnet G. Beauvais D, et al. Among authors: algalarrondo v. J Neurol Neurosurg Psychiatry. 2024 May 14;95(6):489-499. doi: 10.1136/jnnp-2023-332180. J Neurol Neurosurg Psychiatry. 2024. PMID: 37875336 Free PMC article.
Brugada syndrome and abnormal splicing of SCN5A in myotonic dystrophy type 1.
Wahbi K, Algalarrondo V, Bécane HM, Fressart V, Beldjord C, Azibi K, Lazarus A, Berber N, Radvanyi-Hoffman H, Stojkovic T, Béhin A, Laforêt P, Eymard B, Hatem S, Duboc D. Wahbi K, et al. Among authors: algalarrondo v. Arch Cardiovasc Dis. 2013 Dec;106(12):635-43. doi: 10.1016/j.acvd.2013.08.003. Epub 2013 Oct 17. Arch Cardiovasc Dis. 2013. PMID: 24140416 Free article.
Effect of age on survival and causes of death after primary prevention implantable cardioverter-defibrillator implantation.
Fauchier L, Marijon E, Defaye P, Piot O, Sadoul N, Perier MC, Gras D, Klug D, Algalarrondo V, Bordachar P, Deharo JC, Leclercq C, Babuty D, Boveda S; DAI-PP Investigators. Fauchier L, et al. Among authors: algalarrondo v. Am J Cardiol. 2015 May 15;115(10):1415-22. doi: 10.1016/j.amjcard.2015.02.031. Epub 2015 Feb 18. Am J Cardiol. 2015. PMID: 25784518
Causes-of-death analysis of patients with cardiac resynchronization therapy: an analysis of the CeRtiTuDe cohort study.
Marijon E, Leclercq C, Narayanan K, Boveda S, Klug D, Lacaze-Gadonneix J, Defaye P, Jacob S, Piot O, Deharo JC, Perier MC, Mulak G, Hermida JS, Milliez P, Gras D, Cesari O, Hidden-Lucet F, Anselme F, Chevalier P, Maury P, Sadoul N, Bordachar P, Cazeau S, Chauvin M, Empana JP, Jouven X, Daubert JC, Le Heuzey JY; CeRtiTuDe Investigators. Marijon E, et al. Eur Heart J. 2015 Nov 1;36(41):2767-76. doi: 10.1093/eurheartj/ehv455. Epub 2015 Sep 1. Eur Heart J. 2015. PMID: 26330420 Free PMC article.
Impact of early complications on outcomes in patients with implantable cardioverter-defibrillator for primary prevention.
Ascoeta MS, Marijon E, Defaye P, Klug D, Beganton F, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Boveda S, Piot O; DAI-PP Investigators. Ascoeta MS, et al. Among authors: algalarrondo v. Heart Rhythm. 2016 May;13(5):1045-1051. doi: 10.1016/j.hrthm.2015.12.046. Epub 2016 Jan 1. Heart Rhythm. 2016. PMID: 26749313 Free article.
Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women-Data From a Multicenter French Registry.
Providência R, Marijon E, Lambiase PD, Bouzeman A, Defaye P, Klug D, Amet D, Perier MC, Gras D, Algalarrondo V, Deharo JC, Leclercq C, Fauchier L, Babuty D, Bordachar P, Sadoul N, Piot O, Boveda S. Providência R, et al. Among authors: algalarrondo v. J Am Heart Assoc. 2016 Feb 12;5(2):e002756. doi: 10.1161/JAHA.115.002756. J Am Heart Assoc. 2016. PMID: 26873687 Free PMC article.
Does defibrillation testing influence outcomes after CRT-D implantation? A cause-of-death analysis from the DAI-PP study.
Perrin T, Mechulan A, Boveda S, Beganton F, Defaye P, Sadoul N, Piot O, Klug D, Gras D, Perier MC, Algalarrondo V, Bordachar P, Babuty D, Fauchier L, Leclercq C, Marijon E, Deharo JC; DAI-PP Investigators. Perrin T, et al. Among authors: algalarrondo v. Int J Cardiol. 2016 Oct 15;221:951-6. doi: 10.1016/j.ijcard.2016.06.189. Epub 2016 Jun 30. Int J Cardiol. 2016. PMID: 27441474
102 results